Please assess the completion status of the following clinical trial:

Trial Title: A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Require primary or secondary nerve injury repair with Hollow Nerve Conduit or AVANCE™ in at least 1 digital nerve;~* Undergo End to End nerve to nerve graft coaptation on both the proximal and distal portion of the nerve gap in the AVANCE™ group or nerve entubulation in the Hollow Nerve Conduit group;~* Be willing to comply with all aspects of the treatment and evaluation schedule over a 12 Month duration; and~* Sign and date an IRB-approved written informed consent prior to initiation of any study procedures, including screening procedures.~Exclusion Criteria:~* Nerve gaps of \< 5 mm or \> 20 mm;~* Estimated distance of regeneration of \>125 mm (distance from injury site to sensory target)~* Nerve crush or avulsion injuries;~* Incomplete nerve transections;~* Injury requiring replantation of target digit;~* Contralateral digital injuries corresponding to the target digit;~* Nerve injuries in the affected limb proximal to the crease of the wrist;~* End to side nerve repair;~* Injuries with significant vascular damage which may impair adequate perfusion of the target limb;~* Subjects who are undergoing treatment with chemotherapy, radiation therapy, or other know treatment which affects the growth of neural and/or vascular system;~* Use of bovine collagen based hollow nerve conduit in a subject with known or suspected bovine sensitivity;~* Subjects age ≤18 years or ≥70 years;~* History neuropathy, diabetic or any other known neuropathy;~* Secondary nerve repair \>12 weeks post initial injury;~* Currently enrolled in another investigational study;~* Expected use of medications during the study that are known to cause peripheral neuropathy;~* History or Reynaud's or other disorder known to compromise circulation or sensation in the upper extremity; and~* Any subject who at the discretion of the Investigator is not suitable for inclusion in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Avance Nerve Graft (Type: ACTIVE_COMPARATOR): Commercially available Avance Nerve Graft for repair of nerve gap
- Hollow Tube Conduit (Type: ACTIVE_COMPARATOR): Commercially available hollow tube conduit for repair of nerve gap.

Based on this trial design, predict the completion outcome and termination type (if applicable).